Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.

@article{Karenfort2009RituximabAA,
  title={Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.},
  author={Michael Karenfort and Bernd C. Kieseier and Daniel Tibussek and Birgit E Assmann and Joerg Schaper and Ertan Mayatepek},
  journal={Developmental medicine and child neurology},
  year={2009},
  volume={51 2},
  pages={159-61}
}
Michael Karenfort MD, Bernd C Kieseier MD, Daniel Tibussek MD, Birgit Assmann MD, Joerg Schaper MD, Ertan Mayatepek MD 1 Department of General Pediatrics, Heinrich-Heine-University, D sseldorf, Germany. 2 Department of Neurology, Heinrich-Heine-University, D sseldorf, Germany. 3 Department of Diagnostic Radiology, Heinrich-Heine-University, D sseldorf, Germany. Correspondence to: michael.karenfort@med.uni-duesseldorf.de 

From This Paper

Figures, tables, and topics from this paper.
11 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

US Food and Drug Administration, 2006

  • MD FDA Public Health Advisory. Life-threatening brain Rockville
  • http://www.fda.gov/cder/drug/ advisory/rituximab…
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…